In this Monday, April 5, 2021 file photo, cases of Coca-Cola are displayed in a supermarket, in New York. Coca-Cola Co. says its sales are steadily improving as vaccination rates increase and venues like stadiums, restaurants and theaters reopen around the world. The company said its sales rose 5% in the January-March period this year, helped by strong growth in China and India. (AP Photo/Mark Lennihan, File)
Sales are steadily improving at Coca-Cola Co. as vaccinations allow for the opening of stadiums, restaurants and theaters in many regions globally.
Sales rose 5% in the January-March period this year, the Atlanta company said Monday, helped by strong growth in China and India. But the recovery is uneven. Case volume declined in North America and Europe, where many dining rooms and other venues remain closed.
Net income dropped 19% to $2.2 billion in the first quarter. Excluding one-time items, the company earned 55 cents per share. That exceeded Wall Street’s forecast of 50 cents, according to analysts polled by FactSet.
Coke’s revenue rose 5% to $9.0 billion, ahead of the $8.6 billion analysts had forecast.
Before you consider Coca-Cola, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Coca-Cola wasn't on the list.
While Coca-Cola currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report